PF4 inhibits thrombin-stimulated MMP-1 and MMP-3 metalloproteinase expression in human vascular endothelial cells

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 320, Issue 11, 1997, Pages 857-868

  Klein Soyer, Claudine ^a   Duhamel Clérin, Emmanuelle ^a   Ravanat, Catherine ^a   Orvain, Christophe ^b   Lanza, François ^a   Cazenave, Jean Pierre ^a  

^a INSERM   (France)

^b IRCAD   (France)

Author keywords

Endothelial cells; Interstitial collagenase; PF4; Stromelysin 1; Thrombin

Indexed keywords

COLLAGENASE; HEPARAN SULFATE; METALLOPROTEINASE; STROMELYSIN; THROMBIN; THROMBIN RECEPTOR; THROMBOCYTE FACTOR 4;

AMINO ACID SEQUENCE; ARTICLE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; VASCULAR ENDOTHELIUM;

EID: 18344413375     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(97)80870-0     Document Type: Article

References (45)

1. Ten Dijke P., Iwata K.K. 1989. Growth factors for wound healing. Bio/Technol. 7, 793-798
2. Klagsbrun M., D'Amore P.A. 1991. Regulators of angiogenesis. Ann. Rev, Physiol. 53, 217-239
3. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31
4. Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., Carson H.F., Sharpe R.J. 1990. Inhibition of angiogenesis by recombinant human platelet factor 4 and related peptides. Science 247, 77-79
5. Maione T.E., Gray G.S., Hunt A.J., Sharpe R.J. 1991. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51, 2077-2083
6. Sharpe R.J., Byers H.R., Scott C.F., Bauer S.I., Maione T.E. 1990. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J. Natl. Cancer Invest. 82, 848-853
7. Folkman J. 1995. Clinical applications of research on angiogenesis. New Engl. J. Med. 333, 1757-1763
8. Sato Y., Abe M., Takaki R. 1990. Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem. Biophys. Res. Commun. 172, 595-600
9. Horton J.E., Harper J., Harper E. 1980. Platelet factor 4 regulates osteoclastic bone resorption in vitro. Biochim. Biophys. Acta 630, 459-462
10. Hiti-Harper J., Wohl H., Harper E. 1978. Platelet factor 4: an inhibitor of collagenase. Science 199, 991-992
11. Lonky S. A., Wohl H. 1981. Stimulation of human leukocyte elastase by platelet factor 4. J. Clin. Invest. 67, 817-826
12. Hanemaaijer R., Koolwijk P., Clercq L.L., De Vree W.J.A., van Hinsbergh V.W.M. 1993. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem. J. 296, 803-809
13. Partridge C.A., Jeffrey J.J., Malik A.B: 1993; A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability. Lung Cell. Mol. Physiol. 9, L438-L447
14. Furie B., Furie B.C. 1992 Molecular and cellular biology of blood coagulation. New Engl. J. Med. 326, 800-806
15. Zucker S., Conner C., DiMassimo B.I., Ende H., Drews M., Seiki M., Bahou W.F. 1995. Thrombin induces the activation of progeratinase A in vascular endothelial cells. J. Biol. Chem. 270, 23730-23738
16. Duhamel-Clérin E., Orvain C., Lanza F., Cazenave J.P., Klein-Soyer, C. 1997. Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17, 1931-1938
17. Ngai P.K., Chang J.Y. 1991. A novel one-step purification of human α-thrombin. Biochem. J. 280, 805-808
18. Ravanat C., Gachet C., Herbert J.M., Schuhler S., Guillemot J.C., Uzabiaga F., Picard C., Ferrara P., Freund M., Cazenave J.P. 1994. Rat platelets contain glycosylated and non glycosylated forms of platelet factor 4. Identification and characterization by mass spectrometry. Eur. J. Biochem. 223, 203-210
19. Klein-Soyer C., Cazenave J.P. 1986; Culture de cellules endothéliales vasculaires humaines. In: Physiopathologie de l'hémostase et de la thrombose. Progrès en hématologie vol. 8 (Sultan Y., Fischer A.M., eds.), Doin Editeurs, Paris, 83-93
20. Mazzucotelli J.P., Klein-Soyer C., Beretz A., Brisson C., Archipoff G., Cazenave J.P. 1991. Endothelial cell seeding: coating of Dacron and expanded polytetrafluoroethylene vascular grafts with a biological glue allows adhesion and growth of human saphenous vein endothelial cells. Int. J. Artif. Organs 14, 482-490
21. Yayon A., Klagsbrun M., Esko J.D., Leder P., Ornitz D.M. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 132, 841-848
22. Brown P.D., Levy A.T., Margulies I.M.K., Liotta L.A., Stetler-Stevenson W.G. 1990. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50, 6184-6191
23. Woessner J.F.Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154
24. Archipoff G., Beretz A., Bartha K., Brisson C., de la Salle C., Froger-Léon C., Klein-Soyer C., Cazenave J.P. 1993. Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities. Br. J. Pharmacol. 109, 18-28
25. Sambrook J., Fritsch E.F., Maniatis T. 1989. Molecular cloning. In: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
26. Muller D., Quantin B., Gesnel M.C., Millon-Collard R., Abecassis J., Breathnach R. 1988. The collagenase gene family in humans consists of at least four members. Biochem. J. 253, 187-192
27. Carmichaël D.F., Sommer A., Thompson R.C., Anderson D.C., Smith G.G., Welgus H.G., Striklin G.P. 1986. Primary structure and cDNA cloning of human fibroblast collagenase inhibition. Proc. Natl. Acad. Sci. USA 83, 2407-2411
28. Boone T.C., Johnson M.J., De Clerk Y.A., Langley K.E. 1990. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibition of metalloproteinases. Proc. Natl. Acad. Sci. USA 87, 2800-2804
29. Feinberg A.P., Vogelstein B. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13
30. Capitanio A.M., Niewiarowski S., Rucinski B., Tuszynski G.P. 1985. Interaction of platelet factor 4 with human platelets. Biochem. Biophys. Acta 839, 161-173
31. Vu T.K.H., Hung D.T., Wheaton V.I., Coughlin S.R. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068
32. Busch C., Dawes J., Pepper D.S., Wasteson Å. 1980, Binding of platelet factor 4 to cultured humar umbilical vein endothelial cells. Thromb. Res. 19, 129-137
33. Rybak M.E., Gimbrone M.A.Jr., Davies P.F., Handin R.I. 1989. Interaction of platelet factor four with cultured endothelial cells. Blood 73, 1534-1539
34. Nugent M.A., Edelman R. 1992, Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycar: a mechanism of cooperativity. Biochemistry 31, 8876-8883
35. Rotilio D., Tamburro A., Zanni M., Donati M.B. 1993. Multiple effects of thrombin on extracellular matrix degradation: evidence that de novo synthesis of metalloproteases is involved. Thromb. Haemostas. 69, 1551 (abstract)
36. Galis Z.S., Kranzhöfer R., Fenton II J.W., Libby P. 1997. Thrombin promotes activation of martrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler. Thromb Vasc. Biol. 17, 483-489
37. Zucker M.B., Katz I.R. 1991. Platelet factor 4: production, structure and physiologic and immunologic action. Proc. Soc. Exp. Biol. Med. 198, 693-702
38. Files J.C., Malpas T.W., Yee E.K., Ritchie J.L., Harker L.A. 1981. Studies of human platelet α-granule release in vivo. Blood 58, 607-618
39. Brown P.D. 1993. Matrix metalloproteinase inhibitors: a new class of anticancer agent. Curr. Opin. Invest. Drugs 2, 617-626
40. Pellegrini A., Hägeli G., Fretz D., von Fellenberg R. 1984. Natural protease inhibitors: qualitative and quantitative assay by fibrinogen-agarose electrophoresis. Anal. Biochem 138, 335-339
41. Slungaard A., Nelsestuen G.L., Key N.S. 1995. Platelet factor 4 (PF4) binds to the γ-carboxyglutamic acid (Gla) domain of plasma clotting factors and impairs tissue factor (TF) -mediated coagulation. Thromb. Haemostas. 73, 1089 (abstract)
42. Carr M.E., White G.C. 1987. PF4 enhances fibrin fiber polymerization. Thromb. Res. 45, 539-543
43. 165 using several concurrent mechanisms. J. Biol. Chem. 270, 15059-15065
44. Ray J.M., Stetler-Stevenson W.G. 1994. The role of matrix metalloproteinases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062-2072
45. Ries C., Petrides P.E. 1995. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler 376, 345-355